How can I apply Light's criteria (pleural fluid protein/serum protein > 0.5, pleural fluid lactate dehydrogenase/serum lactate dehydrogenase > 0.6, or pleural fluid lactate dehydrogenase > 2/3 of the upper limit of normal) to distinguish an exudative from a transudative pleural effusion, and what adjunctive tests help when diuretic therapy or heart failure may cause false‑positive exudates?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Light's Criteria for Pleural Effusion Classification

Primary Diagnostic Approach

Apply Light's criteria by measuring simultaneous pleural fluid and serum samples: classify as exudate if ANY ONE of these is met: pleural fluid/serum protein ratio >0.5, pleural fluid/serum LDH ratio >0.6, or pleural fluid LDH >2/3 the upper limit of normal serum LDH. 1, 2

Performance Characteristics

  • Sensitivity: 97.5–98% for identifying exudates 2, 3
  • Specificity: 70–80% for identifying exudates 2, 3
  • Positive likelihood ratio: 3.5; Negative likelihood ratio: 0.03 2
  • Meeting none of the three criteria indicates a transudate 2

Critical Limitation

Light's criteria misclassify approximately 25–30% of cardiac and hepatic transudates as exudates, particularly in patients receiving diuretics 2, 3, 4. This is the most common pitfall in clinical practice.


Correcting False-Positive Exudates

When Light's criteria suggest exudate but clinical context (heart failure, cirrhosis, diuretic therapy) points to transudate, apply these adjunctive tests in order:

For Suspected Heart Failure

  1. Serum-effusion albumin gradient (SEAG): serum albumin minus pleural fluid albumin >1.2 g/dL reclassifies ~80–83% of false exudates as transudates with 97.5% accuracy 2, 5, 4

  2. Pleural fluid/serum albumin ratio <0.6 indicates transudate (78% accuracy for cardiac effusions) 2, 4

  3. NT-proBNP: serum or pleural fluid >1500 pg/mL confirms heart failure with 92–94% sensitivity and 88–91% specificity 2

    • Serum NT-proBNP is preferred; pleural fluid measurement offers no advantage 6

For Suspected Hepatic Hydrothorax

  • Pleural fluid/serum albumin ratio <0.6 has 77–78% accuracy for correctly identifying liver-related transudates misclassified by Light's criteria 2, 4

Clinical Scoring Alternative

  • Porcel clinical scoring model ≥7 points indicates cardiac etiology with 92% accuracy (positive LR 12.7, negative LR 0.39) 2

Alternative When Serum Unavailable

If venipuncture is not feasible, use pleural fluid LDH >67% of upper limit of normal serum LDH AND pleural fluid cholesterol >55 mg/dL as an alternative with comparable discriminative capacity to Light's criteria 2, 7. However, this is an unusual circumstance and simultaneous serum sampling remains the standard.


Essential Practical Considerations

Sample Collection

  • Collect pleural fluid and serum simultaneously to ensure accurate ratio calculations 2
  • Send all samples for protein, LDH, pH, glucose, cytology, Gram stain, AFB stain, and culture in sterile vials plus blood culture bottles 6

Laboratory Variability Pitfall

  • Up to 18% discordance in classification can occur between different laboratory analyzers, particularly affecting LDH measurements 2, 8
  • LDH assays may perform differently in serum versus pleural fluid 8

Clinical Context Overrides

  • Do not aspirate bilateral effusions in clinically obvious transudates (e.g., symmetric effusions with clear heart failure) unless atypical features present or failure to respond to therapy 6
  • Diuretic therapy is the single most common cause of transudate misclassification as exudate 2

Diagnostic Algorithm Summary

  1. Apply Light's criteria first (98% sensitivity for exudates) 1, 2, 3
  2. If exudate by Light's but clinical picture suggests transudate:
    • Heart failure suspected → SEAG >1.2 g/dL or NT-proBNP >1500 pg/mL 2
    • Cirrhosis suspected → Pleural fluid/serum albumin ratio <0.6 2, 4
  3. If transudate by Light's criteria: no further biochemical testing needed for classification 2

This approach maximizes detection of serious exudative causes (malignancy, infection) while providing tools to rescue the 25–30% of transudates incorrectly labeled as exudates 2, 3, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria for Pleural Effusions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Approach to Pleural Effusion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pleural Fluid Analysis Parameters

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the extended Light criteria for pleural effusion, their sensitivity and specificity, and how do they compare to the regular Light criteria?
What are Light's (criteria) used for in differentiating pleural effusions?
What are the treatment approaches for pleural effusions based on Light's criteria?
What is the diagnostic value of pleural fluid uric acid and its ratio to serum uric acid in cases of pleural effusion and its correlation with Light's (Lactate Dehydrogenase) criteria?
What is the most likely diagnosis for a patient with an exudative pleural effusion, serum Lactate Dehydrogenase (LDH) of 100, pleural LDH of 200, serum protein of 60, and pleural protein of 35?
Is it appropriate to give Claritin (loratadine) 5 mg to a 17‑month‑old infant?
Can dehydration cause urinary tract infection in a healthy adult woman?
What is the first-line treatment for an adult with symptomatic bradycardia?
What is the recommended treatment for hepatic encephalopathy, including first‑line therapy, dosing, and management of precipitating factors?
What is the appropriate evaluation and management for a tender lesion on the pinna?
In a patient with congestive heart failure on carvedilol who develops grade IV anaphylaxis with extreme bradycardia and refractory hypotension after intramuscular epinephrine, why is carvedilol (an α1, β1, and β2 antagonist) particularly problematic at the molecular level, and if glucagon is unavailable or ineffective, which vasopressor that acts directly on α1 receptors should be used?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.